Open-Angle Glaucoma Epidemiology Forecast 2026-2035

Read more about this report - Request a Free Sample

Open-Angle Glaucoma Epidemiology Forecast Report Coverage

Expert Market Research's “Open-Angle Glaucoma Epidemiology Forecast Report 2026-2035” offers comprehensive information on the prevalence and demographics of open-angle glaucoma. It projects the future incidence and prevalence rates of open-angle glaucoma cases across various populations. The study covers age, gender, and type as major determinants of the open-angle glaucoma population. The report highlights patterns in the prevalence of open-angle glaucoma over time and projects future trends based on multiple variables.

Open-Angle Glaucoma Understanding: Disease Overview

Open-angle glaucoma is a chronic, progressive optic neuropathy characterized by damage to the optic nerve and corresponding visual field loss, typically with an anatomically open anterior chamber angle. The disease commonly develops when aqueous humor drainage through the trabecular meshwork becomes impaired, resulting in elevated or dysregulated intraocular pressure and progressive retinal ganglion cell loss. The principal types include primary open-angle glaucoma (POAG), the most common form, and secondary open-angle glaucoma, which may result from conditions such as pseudoexfoliation, pigment dispersion, trauma, inflammation, or corticosteroid exposure.

Key Report Insights

Open-Angle Glaucoma Epidemiology Perspective

The open-angle glaucoma epidemiology division offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. Expert Market Research provides both current and predicted trends for the open-angle glaucoma epidemiology scenario by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for open-angle glaucoma and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.

Type-Specific Disease Burden and Epidemiology Analysis

Read more about this report - Request a Free Sample

Country-wise Open-Angle Glaucoma Epidemiology

The open-angle glaucoma epidemiology data and findings for the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

Key Market Gaps, Untapped Opportunities, and Emerging Growth Areas in the Regional Disease Epidemiology Landscape

The regional open-angle glaucoma landscape continues to face a substantial early-detection gap, particularly because glaucoma can progress with limited symptoms before irreversible visual impairment becomes apparent. Recent European evidence indicates that more than half of glaucoma cases may remain undiagnosed, underscoring the need for broader population risk assessment and timely ophthalmic evaluation. Aging populations across the United States, Europe, Japan, and India are expected to increase the underlying disease burden. Opportunities include expanded screening of high-risk populations, improved access to comprehensive eye examinations, earlier diagnosis, and greater use of technologies that support optic nerve and visual field assessment.

Open-Angle Glaucoma: Treatment Overview

Open-angle glaucoma treatment aims to slow or prevent further optic nerve damage and preserve visual function, primarily by lowering intraocular pressure. First-line management commonly involves topical medications, including prostaglandin analogs, beta-blockers, alpha-adrenergic agonists, and carbonic anhydrase inhibitors. Selective laser trabeculoplasty may be used as an initial or adjunctive treatment. For patients with inadequate control or progressive disease, surgical device approaches such as minimally invasive glaucoma surgery, trabeculectomy, or glaucoma drainage devices may be considered. Intraocular pressure reduction remains the central therapeutic objective throughout disease management.

Key Questions Answered

• What is the current and projected burden of open-angle glaucoma across the 8 major markets?
• Which countries across the 8 major markets account for the highest open-angle glaucoma patient populations and fastest growth rates?
• What is the diagnosed versus undiagnosed patient population of open-angle glaucoma across key countries in the 8 major markets?
• Which countries demonstrate the largest gaps in screening, early diagnosis, and disease awareness of open-angle glaucoma across the 8 major markets?
• What are the major drivers contributing to the increasing burden of open-angle glaucoma across the 8 major markets?
• How do major comorbidities and risk factors influence open-angle glaucoma trends across the 8 major markets?
• What are the regional trends in advanced disease progression, treatment uptake, and patient management of open-angle glaucoma across the 8 major markets?
• Which patient segments represent the highest unmet clinical need in the open-angle glaucoma landscape across the 8 major markets?
• Which therapeutic areas linked to open-angle glaucoma are expected to witness the strongest growth opportunities across the 8 major markets?
• How is the open-angle glaucoma epidemiology landscape expected to evolve over the next 5 to 10 years across the 8 major markets?
• Which countries across the 8 major markets offer the most attractive market opportunities based on open-angle glaucoma epidemiology and healthcare infrastructure?
• Which epidemiological trends are expected to influence future drug development and market access strategies for open-angle glaucoma across the 8 major markets?

Scope of the Open-Angle Glaucoma Epidemiology Report

• The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of open-angle glaucoma based on several factors.
• Open-Angle Glaucoma Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
• The open-angle glaucoma report helps to identify the patient population, and the unmet needs are highlighted along with an assessment of the disease's risk and burden.

Related Reports

Glaucoma Therapeutics Market

Glaucoma Pipeline Analysis

Primary Open Angle Glaucoma Epidemiology Forecast